- Report
- April 2023
- 80 Pages
Japan
From €1355EUR$1,500USD£1,159GBP
- Report
- April 2023
- 80 Pages
Ireland
From €1355EUR$1,500USD£1,159GBP
- Report
- April 2023
- 80 Pages
India
From €1355EUR$1,500USD£1,159GBP
- Report
- April 2023
- 80 Pages
Germany
From €1355EUR$1,500USD£1,159GBP
- Report
- April 2023
- 80 Pages
France
From €1355EUR$1,500USD£1,159GBP
- Report
- April 2023
- 80 Pages
China
From €1355EUR$1,500USD£1,159GBP
- Report
- April 2023
- 80 Pages
Brazil
From €1355EUR$1,500USD£1,159GBP
- Report
- April 2023
- 80 Pages
Argentina
From €1355EUR$1,500USD£1,159GBP
- Report
- April 2023
- 255 Pages
Global
From €2259EUR$2,500USD£1,931GBP
- Report
- April 2023
- 180 Pages
Global
From €2259EUR$2,500USD£1,931GBP
- Report
- April 2023
- 100 Pages
Africa
From €1807EUR$2,000USD£1,545GBP
- Newsletter
- June 2025
- 4 Pages
Global
From €181EUR$200USD£154GBP
- Report
- October 2024
- 70 Pages
China
From €858EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
France
From €858EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Germany
From €858EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
India
From €858EUR$950USD£734GBP
- Report
- July 2024
- 90 Pages
China
From €1626EUR$1,800USD£1,390GBP
- Report
- July 2024
- 326 Pages
China
From €3614EUR$4,000USD£3,090GBP
- Report
- July 2024
- 243 Pages
China
From €3614EUR$4,000USD£3,090GBP
- Report
- July 2024
- 187 Pages
China
From €1626EUR$1,800USD£1,390GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more